Fight COVID-19

GS™ COVID-19 RealTime-PCR Kit

Quick & Reliable Solutions for
Coronavirus Disease (COVID-19) and SARS-CoV-2

Order For use under the Emergency Use Authorization (EUA) only.

For in vitro diagnostic use.

A novel coronavirus disease (COVID) outbreak was first reported to the World Health Organization (WHO) in December 2019. The SARS-COV-2 virus has spread rapidly throughout the world and the WHO raised the alert identifying COVID-19 as a pandemic on March 11, 2020.

The GSTM COVID-19 RT-PCR KIT provides accurate, reproducible, high-quality results for clinical decision-making for patients with suspected COVID-19 (coronavirus) infection. The GSTM COVID-19 RT-PCR KIT performs a qualitative molecular assay that allows the detection of SARS-COV-2 nucleic acids in samples from patients who meet COVID-19 clinical and/or epidemiological criteria. 

The GSTM COVID-19 RT-PCR KIT is a real-time reverse transcription polymerase chain reaction (RT-PCR) test which detects three genes from the SARS-CoV-2 virus from clinical nasopharyngeal swab specimens. In addition, the GSTM COVID-19 RT-PCR KIT also includes an internal positive control gene (GUSB) that serves as an extraction, reverse transcription, and PCR amplification control for each sample to minimize false negative results.

Features of the newly developed diagnostic kit:

  • Accuracy: Assay 3 target genes unique to SARS-CoV-2 having higher specificity and exhibiting lower risk for mutation
  • Specificity: Targeted specificity to 100% of currently available complete genomes for SARS-CoV-2.      
  • Simplicity: Ready to use all-in-one master mix reagents and controls minimize      variability
  • Throughput: Two kit  package options of viral detection for up to 94 specimens 
  • High quality, high performance and reliability

Cat #

Product Name





GS™ COVID-19 Real-Time PCR Kit – 22

Provide all-in-one master mix including cDNA synthesis, PCR mix, primers and probe of each gene.


Request a quote


GS™ COVID-19 Real-Time PCR Kit – 94

Provide all-in-one master mix including cDNA synthesis, PCR mix, primers and probe of each gene.


Request a quote



Letter of Authorization

Fact Sheet provider

Fact Sheet patient

For more up-to-date information on the current coronavirus outbreak, visit the WHO or CDC websites.

Contact us if you want to order or call 1-480-598-5378 for more questions. Please allow up to 48 hours for a response to your quote request.

• This test has not been FDA cleared or approved;

 • This test has been authorized by FDA under an EUA for use by authorized laboratories;

 • This test has been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens; and,

 • This test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.